Y0001832

Irinotecan hydrochloride trihydrate

European Pharmacopoeia (EP) Reference Standard

• 同義詞: Irinotecan monohydrochloride trihydrate, [1,4′-Bipiperidine]-1′-carboxylic acid (S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl ester monohydrochloride trihydrate
• 經驗公式（希爾表示法）: C₃₃H₃₈N₄O₆ · HCl · 3H₂O
• CAS號碼: 136572-09-3
• 分子量：: 677.18
• 分類程式碼代碼: 41116107
• NACRES: NA.24

屬性

• API 家族: irinotecan
• 儲存溫度: 2-8°C
• SMILES 字串: [Cl-].N21Cc3c(nc5c(c3CC)cc(cc5)OC(=O)N6CCC(CC6)N7CCCCC7)C2=CC4=C(COC(=O)[C@]4(O)CC)C1=O.O.O.O.[H+]
• InChI: 1S/C33H38N4O6.ClH.3H2O/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2;;;;/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3;1H;3*1H2/t33-;;;;/m0..../s1
• InChI 密鑰: KLEAIHJJLUAXIQ-JDRGBKBRSA-N

描述

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

包裝

Unit quantity: 170 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他說明

Sales restrictions may apply.

安全資訊

• 象形圖: GHS07
• 訊號詞: Warning
• 危險聲明: H302
• 防範說明: P301 + P312 + P330
• 危險分類: Acute Tox. 4 Oral
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable